{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-10",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20230127",
          "review_priority": "PRIORITY",
          "submission_class_code": "TYPE 1",
          "submission_class_code_description": "Type 1 - New Molecular Entity",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "73350",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216059Orig1s000Corrected_lbl.pdf",
              "date": "20230131",
              "type": "Label"
            },
            {
              "id": "73489",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/216059Orig1s000Corrected_ltr.pdf",
              "date": "20230214",
              "type": "Letter"
            },
            {
              "id": "73601",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2023/216059Orig1s000TOC.html",
              "date": "20230224",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "5",
          "submission_status": "AP",
          "submission_status_date": "20251202",
          "review_priority": "STANDARD",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "84352",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2025/216059s005lbl.pdf",
              "date": "20251208",
              "type": "Label"
            },
            {
              "id": "84368",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/216059Orig1s005ltr.pdf",
              "date": "20251209",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20231201",
          "review_priority": "PRIORITY",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "76716",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216059s001lbl.pdf",
              "date": "20231201",
              "type": "Label"
            },
            {
              "id": "76726",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/216059Orig1s001ltr.pdf",
              "date": "20231205",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20240604",
          "review_priority": "901 REQUIRED",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "78631",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/216059Orig1s002ltr.pdf",
              "date": "20240605",
              "type": "Letter"
            },
            {
              "id": "78652",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2024/216059s002lbl.pdf",
              "date": "20240605",
              "type": "Label"
            }
          ]
        }
      ],
      "application_number": "NDA216059",
      "sponsor_name": "LOXO ONCOL",
      "openfda": {
        "application_number": [
          "NDA216059"
        ],
        "brand_name": [
          "JAYPIRCA"
        ],
        "generic_name": [
          "PIRTOBRUTINIB"
        ],
        "manufacturer_name": [
          "Eli Lilly and Company"
        ],
        "product_ndc": [
          "0002-7026",
          "0002-6902"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "PIRTOBRUTINIB"
        ],
        "rxcui": [
          "2629343",
          "2629349",
          "2629351",
          "2629353"
        ],
        "spl_id": [
          "ef421dc8-11db-4e6c-9154-dc04782cb52c"
        ],
        "spl_set_id": [
          "bd551845-0878-49a4-860f-839b83f6b801"
        ],
        "package_ndc": [
          "0002-6902-30",
          "0002-7026-60",
          "0002-7026-99"
        ],
        "nui": [
          "N0000175605",
          "N0000193934",
          "N0000185503",
          "N0000187062",
          "N0000182140",
          "N0000190114",
          "N0000190113"
        ],
        "pharm_class_epc": [
          "Kinase Inhibitor [EPC]"
        ],
        "pharm_class_moa": [
          "Bruton's Tyrosine Kinase Inhibitors [MoA]",
          "P-Glycoprotein Inhibitors [MoA]",
          "Cytochrome P450 2C8 Inhibitors [MoA]",
          "Cytochrome P450 2C19 Inhibitors [MoA]",
          "Cytochrome P450 3A Inhibitors [MoA]",
          "Breast Cancer Resistance Protein Inhibitors [MoA]"
        ],
        "unii": [
          "JNA39I7ZVB"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "JAYPIRCA",
          "active_ingredients": [
            {
              "name": "PIRTOBRUTINIB",
              "strength": "50MG"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "TABLET",
          "route": "ORAL",
          "marketing_status": "Prescription"
        },
        {
          "product_number": "002",
          "reference_drug": "Yes",
          "brand_name": "JAYPIRCA",
          "active_ingredients": [
            {
              "name": "PIRTOBRUTINIB",
              "strength": "100MG"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "TABLET",
          "route": "ORAL",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}